Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the Study Details page. This reflects a page metadata revision rather than modifications to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-01T19:31:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a newer release of the study details page. The visible content remains unchanged; the change reflects an internal version update.
    Difference
    0.0%
    Check dated 2026-08-11T18:02:40.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision history now shows a new version, v3.6.4, superseding the previous v3.6.3. This indicates a backend/content update to the page rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-07-28T14:58:53.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record. This update appears to be a metadata revision rather than a change to study content or functionality.
    Difference
    0.0%
    Check dated 2026-06-30T02:14:58.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended by stating 'No longer looking for participants' and adds sections to help readers read a study record, view common questions, and learn how to join. It also standardizes the Intervention/Treatment heading and notes the new revision version v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T22:01:38.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This update does not modify the study text or results shown on the page.
    Difference
    0.0%
    Check dated 2026-06-08T17:46:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.